Sign in

CIK 0001274737 · Non-accelerated filer<br>Smaller reporting company

EXAGEN INC.

Sign in to watch
Ticker
XGN
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(760) 560-1501
Business address
1261 LIBERTY WAY, VISTA, CA, 92081
Former names
EXAGEN DIAGNOSTICS INC
Open-market buys, last 90 days
$568,660
in 3 filings
Open-market sales, last 90 days
$1,233,534
in 4 filings

Net −$664,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Chernett Jorey −$246K 10% owner sold 7% of stake
  2. ABALLI JOHN −$270K President and CEO sold 4% of stake
  3. Black Jeffrey G. −$149K Chief Financial Officer sold 6% of stake
Date Insider Transaction Shares Price Value Owned after
2020-04-13 PALLARES EBETUEL Director Other disposition −144,033 0
2020-04-13 PALLARES EBETUEL Director Other acquisition +1,185 1,185
2020-04-13 Hunt Holdings Limited Partnership 10% owner Other acquisition +7,703 1,486,518
2020-03-24 Zack Debra Chief Medical Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-03-20 TULLIS JAMES L L Director Other disposition −164,420 1,625,165
2020-03-20 TULLIS DICKERSON CAPITAL FOCUS III, L.P. 10% owner Other disposition −164,420 1,625,165
2020-03-11 PALLARES EBETUEL Director Option exercise +22,427 $1.84 $41K 144,094
2020-03-11 PALLARES EBETUEL Director Shares withheld for taxes −2,112 $19.51 $41K 141,982
2020-03-11 PALLARES EBETUEL Director Option exercise +2,265 $1.84 $4K 144,247
2020-03-11 PALLARES EBETUEL Director Shares withheld for taxes −214 $19.51 $4K 144,033
2020-03-11 PALLARES EBETUEL Director Option exercise · Warrants −22,427 0
2020-03-11 PALLARES EBETUEL Director Option exercise · Warrants −2,265 0
2020-01-09 Rocca Fortunato R. President and CEO Grant or award · Stock Option(right to buy) +155,000 155,000
2020-01-09 Adawi Kamal Chief Financial Officer Grant or award · Stock Option(right to buy) +52,500 52,500
2019-09-23 TULLIS DICKERSON CAPITAL FOCUS III, L.P. 10% owner Conversion +1,786,853 1,789,585
2019-09-23 TULLIS DICKERSON CAPITAL FOCUS III, L.P. 10% owner Conversion · Series A-3 Redeemable Convertible Preferred Stock −468,321 0
2019-09-23 TULLIS DICKERSON CAPITAL FOCUS III, L.P. 10% owner Conversion · Series C Redeemable Convertible Preferred Stock −5,446,902 0
2019-09-23 TULLIS DICKERSON CAPITAL FOCUS III, L.P. 10% owner Conversion · Series E Redeemable Convertible Preferred Stock −53,251,030 0
2019-09-23 TULLIS DICKERSON CAPITAL FOCUS III, L.P. 10% owner Conversion · Series F Redeemable Convertible Preferred Stock −81,166,266 0
2019-09-23 TULLIS DICKERSON CAPITAL FOCUS III, L.P. 10% owner Conversion · Series H Redeemable Convertible Preferred Stock −58,359,932 0

Page 9 of 12 · 239 trades